Literature DB >> 28749707

Imaging findings of Alagille syndrome in young infants: differentiation from biliary atresia.

Solbee Han1, Tae Yeon Jeon1, Sook Min Hwang1, So-Young Yoo1, Yon Ho Choe2, Suk-Koo Lee3, Ji Hye Kim1.   

Abstract

OBJECTIVE: To compare the imaging findings using ultrasonography, MR cholangiopancreatography (MRCP), and intraoperative cholangiography (IOC) between Alagille syndrome (AGS) and biliary atresia (BA) in young infants with cholestatic jaundice.
METHODS: The institutional review board approved this retrospective study. Ultrasonography (n = 55), MRCP (n = 33), and IOC (n = 22) studies were performed in 55 infants (all younger than 3 months) with AGS (n = 7) and BA (n = 48). The ultrasound images were reviewed focusing on gallbladder (GB) abnormalities, triangular cord sign, hepatic artery enlargement and signs of portal hypertension. Visualization of the extrahepatic biliary tree was assessed by MRCP and IOC.
RESULTS: Six (86%) AGS patients showed a small GB on ultrasound; this was comparable to that in BA patients (81%, 35/43). The images were negative for triangular cord sign and hepatic artery enlargement in all AGS patients, whereas they were positive in 48% (23/48) (p = 0.034) and 77% (33/43) (p < 0.001) of the BA patients, respectively. Signs of portal hypertension were less common in AGS patients than in BA patients (p = 0.010). Although non-visualization of the extrahepatic biliary tree by MRCP did not differ significantly between patients with AGS and BA, AGS patients showed a higher proportion of visible common bile ducts with IOC, compared to BA patients. The diagnosis of AGS was made in four infants (57%) before ultrasonography, based on extrahepatic manifestations.
CONCLUSION: The small GB visualized on ultrasonography and non-visualization of extrahepatic biliary tree by MRCP commonly occurred in patients with either AGS or BA. However, triangular cord sign, hepatic artery enlargement and signs of portal hypertension onultrasonography and non-visualized common bile duct with IOC were less frequent in AGS patients than in BA patients. Advances in knowledge: Atypical imaging findings for BA should prompt a meticulous evaluation for the extrahepatic manifestations of AGS to avoid possibly harmful surgery.

Entities:  

Mesh:

Year:  2017        PMID: 28749707      PMCID: PMC5858791          DOI: 10.1259/bjr.20170406

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  29 in total

1.  A prospective pilot study: can the biliary tree be visualized in children younger than 3 months on Magnetic Resonance Cholangiopancreatography?

Authors:  Pascale Siles; Audrey Aschero; Guillaume Gorincour; Brigitte Bourliere-Najean; Bertrand Roquelaure; Arnauld Delarue; Philippe Petit
Journal:  Pediatr Radiol       Date:  2014-04-08

2.  Diagnosis of Alagille syndrome-25 years of experience at King's College Hospital.

Authors:  P Subramaniam; A Knisely; B Portmann; S A Qureshi; W A Aclimandos; J B Karani; A J Baker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-01       Impact factor: 2.839

3.  MR cholangiography in the evaluation of neonatal cholestasis.

Authors:  T S Jaw; Y T Kuo; G C Liu; S H Chen; C K Wang
Journal:  Radiology       Date:  1999-07       Impact factor: 11.105

4.  MR cholangiography in the evaluation of neonatal cholestasis: initial results.

Authors:  Karen I Norton; Ronald B Glass; Debora Kogan; Jacob S Lee; Sukru Emre; Benjamin L Shneider
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

5.  Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.

Authors:  Guido Carpino; Vincenzo Cardinale; Anastasia Renzi; Johannes R Hov; Pasquale Bartolomeo Berloco; Massimo Rossi; Tom H Karlsen; Domenico Alvaro; Eugenio Gaudio
Journal:  J Hepatol       Date:  2015-06-25       Impact factor: 25.083

6.  Consequences of JAG1 mutations.

Authors:  B M Kamath; L Bason; D A Piccoli; I D Krantz; N B Spinner
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

7.  Objective criteria of triangular cord sign in biliary atresia on US scans.

Authors:  Hee-Jung Lee; Sung-Moon Lee; Woo-Hyun Park; Soon-Ok Choi
Journal:  Radiology       Date:  2003-11       Impact factor: 11.105

8.  Arteriohepatic dysplasia. I. Pitfalls in diagnosis and management.

Authors:  J Markowitz; F Daum; E I Kahn; K M Schneider; H B So; R P Altman; H W Aiges; G Alperstein; M Silverberg
Journal:  Hepatology       Date:  1983 Jan-Feb       Impact factor: 17.425

9.  Spleen length in childhood with US: normal values based on age, sex, and somatometric parameters.

Authors:  Stylianos D Megremis; Ioannis G Vlachonikolis; Amalia M Tsilimigaki
Journal:  Radiology       Date:  2004-02-27       Impact factor: 11.105

10.  Outcome of Alagille Syndrome Patients Who Had Previously Received Kasai Operation during Infancy: A Single Center Study.

Authors:  Hwa Pyung Lee; Ben Kang; So Yoon Choi; Sanghoon Lee; Suk-Koo Lee; Yon Ho Choe
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-09-25
View more
  4 in total

Review 1.  Syndromes with aortic involvement: pictorial review.

Authors:  Evan J Zucker
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

Review 2.  Neonatal Jaundice.

Authors:  Pooja Abbey; Devasenathipathy Kandasamy; Priyanka Naranje
Journal:  Indian J Pediatr       Date:  2019-02-21       Impact factor: 1.967

3.  Assessment of Diffusion Tensor Imaging Parameters of Hepatic Parenchyma for Differentiation of Biliary Atresia from Alagille Syndrome.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Reda Elfar; Germeen Albair Ashmalla; Khadiga Ali; Tarik Barakat
Journal:  Korean J Radiol       Date:  2020-07-27       Impact factor: 3.500

4.  Re-evaluation of Laparoscopic Hepatic Subcapsular Spider-Like Telangiectasis Sign: A Highly Accurate Method to Diagnose Biliary Atresia in Infants.

Authors:  Yibo Li; Liying Rong; Jingfeng Tang; Huizhong Niu; Zhu Jin; Yun Zhou; Guoqing Cao; Xi Zhang; Shuiqing Chi; Shaotao Tang
Journal:  Front Pediatr       Date:  2022-04-25       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.